Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/synaptogenix-president-daniel-l-alkon-md-honored-for-scientific-presentation-at-usc-sponsored-forum-on-age-related-diseases-and-neurodegenerative-disorders-302018822.html
https://www.prnewswire.com/news-releases/synaptogenix-joins-leading-neuroscientists-and-academics-as-speaker-at-usc-sponsored-forum-on-age-related-diseases-including-alzheimers-302007192.html
https://www.prnewswire.com/news-releases/synaptogenix-acquires-significant-stake-in-cannasoul-analtyics-ltd-co-founded-by-the-technion---israel-institute-of-technology-301975492.html
https://www.prnewswire.com/news-releases/synaptogenix-announces-peer-reviewed-publication-of-nih-sponsored-phase-2-clinical-trial-results-demonstrating-safe-significant-and-persistent-benefits-of-bryostatin-1-in-advanced-alzheimers-disease-301938588.html
https://www.prnewswire.com/news-releases/bryostatin-1-from-synaptogenix-shows-statistically-significant-results-as-an-als-treatment-in-pre-clinical-independent-study-301920491.html
https://www.prnewswire.com/news-releases/synaptogenix-and-cleveland-clinic-to-submit-investigational-new-drug-ind-application-to-fda-for-clinical-trial-of-bryostatin-1-in-multiple-sclerosis-301880709.html
https://www.prnewswire.com/news-releases/synaptogenix-abstract-highlighting-bryostatin-1-benefits-in-severe-alzheimers-disease-accepted-for-presentation-at-11th-international-brain-research-organization-world-congress-of-neuroscience-301876581.html
https://www.prnewswire.com/news-releases/synaptogenix-provides-corporate-update-and-outlines-potential-business-opportunities-301763508.html
https://endpts.com/alzheimers-fail-crushes-small-biotechs-share-price-to-nearly-penny-stock/
https://endpts.com/alzheimers-fail-crushes-small-biotechs-share-price-to-nearly-penny-stock/